MRL Ventures Fund
MRL Ventures Fund (MRLV), Merck's corporate venture arm, invests globally in early-stage preclinical therapeutics companies to transform patient care.
Cambridge, United States · 8+ investments · 7 portfolio companies
- Headquarters
- Cambridge, United States
- Founded
- 2015
- Website
- mrlv.com
- AUM
- $500.0M
- Portfolio Companies
- 7
- Total Investments
- 8
- Last Investment
- Oct 2024
- Geographic Focus
- Global
Investment Thesis
MRL Ventures Fund is a Corporate VC firm based in Cambridge, United States. It has made 8 investments in Biotech and Healthcare, including Insamo, Alector and Tallac Therapeutics.
Portfolio7
Co-investors24
Sign up to view co-investors
24 co-investors across 28 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×21 · Hedge Fund ×2 · Other ×1 · 29 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/mrl-ventures-fund"><img src="https://indexed.vc/api/badge/investor/mrl-ventures-fund" alt="MRL Ventures Fund on Indexed.vc" width="260" height="76" /></a>
